ENTEROCALM

Welcome to the Brand page for “ENTEROCALM”, which is offered here for Pharmaceutical, medical, and veterinary preparations; drugs for medical purposes; pharmaceutical preparations for use in targeted pharmaceutical therapies; pharmaceutical preparations and products for the treatment of gastrointestinal disorders and diseases; anti-inflammatory drugs; pharmaceutical preparations for treatment, prevention, or alleviation of inflammatory conditions of the gastrointestinal tract; pharmaceutical preparations for treatment, prevention, or alleviation of inflammatory bowel disease (ibd); pharmaceutical preparations for treatment, prevention, or alleviation of crohn's disease and ulcerative colitis; biotechnological preparations for medical use; biological compounds for use in targeted pharmaceutical therapies; drug delivery agents that facilitate the delivery of pharmaceutical preparations; clinical medical reagents; diagnostic and testing preparations for clinical, medical, and medical laboratory use; diagnostic reagents and assays for clinical, medical, and medical laboratory use;.

Its status is currently believed to be active. Its class is unavailable. “ENTEROCALM” is believed to be currently owned by “Enterotarget ApS”.